Zenapax
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for Zenapax, covering 2008-03-04 to 2017-07-02. Get the full timeline:
Most recent: Clinical Trial Update: Zenapax (Daclizumab) to Treat Relapsing Remitting Multiple Sclerosis [Phase 2]